Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
May Abdel-Wahab, MD,PhD, is a Staff Radiation Oncologist and Professor at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. She is board-certified in radiation oncology. Her specialty interests include gastrointestinal cancer, prostate cancer, and research in radiation oncology and hormones.
Dr. Abdel-Wahab graduated with Honors and received her medical degree from Cairo University. She completed her MSc and Doctorate degree and training at the National Cancer Institute at Cairo University. She completed a residency and fellowship in radiation oncology at the University of Miami. Dr. Wahab also completed a fellowship at Crawford Long hospital of Emory University.
Prior to joining the Cleveland Clinic, Dr. Wahab was a tenured faculty and the former Residency Program Director at the University of Miami. Dr Wahab led the cancer center genitourinary cancer site disease group and co-led the SIRT liver cancer program (Yttrium 90 microspheres) program at the University of Miami Sylvester Cancer Center.
Dr. Wahab’s research interests in the lab focus on the effects of antagonists of growth hormone releasing hormone on radiation, collaborating with Nobel laureate Andrew Schally's group to study their interaction with radiation. Clinical research interests include novel radio sensitizers and protectors and targeted therapies. She has authored or co-authored more than 100 articles and abstracts on her specialty interests in leading peer-reviewed medical journals. She has published chapters in medical textbooks on the results of her research and clinical experience. Dr. Wahab's prostate cancer book has been translated into spanish and chinese. She has lectured worldwide on her work in research and clinical practice at medical symposia, conferences and as a visiting professor.
Dr. Wahab is also a member of the American College of Radiology expert taskforce (appropriateness criteria) for prostate and rectal cancer. She is on the editorial board of several scientific journals and was a consultant and an advisor for the International Atomic Energy Agency. Dr. Wahab is a member and chair of several national and international committees. She is interested in healthcare disparities and connectivity in radiation oncology.
Radiation therapy, intraoperative radiation therapy, stereotactic body radiotherapy, radiosurgery, gastrointestinal tumors/cancer, cancer, colorectal cancer, esophageal cancer, liver cancer, pancreatic cancer, stomach cancer, prostate cancer
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 2/2/2014, Dr. Abdel-Wahab has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.